836 related articles for article (PubMed ID: 15379866)
21. Immunomodulatory effect of vitamin C on intracytoplasmic cytokine production in neonatal cord blood cells.
Hartel C; Puzik A; Gopel W; Temming P; Bucsky P; Schultz C
Neonatology; 2007; 91(1):54-60. PubMed ID: 17344653
[TBL] [Abstract][Full Text] [Related]
22. Characterization of rofecoxib as a cyclooxygenase-2 isoform inhibitor and demonstration of analgesia in the dental pain model.
Ehrich EW; Dallob A; De Lepeleire I; Van Hecken A; Riendeau D; Yuan W; Porras A; Wittreich J; Seibold JR; De Schepper P; Mehlisch DR; Gertz BJ
Clin Pharmacol Ther; 1999 Mar; 65(3):336-47. PubMed ID: 10096266
[TBL] [Abstract][Full Text] [Related]
23. Accelerative effect of a selective cyclooxygenase-2 inhibitor on Fas-mediated apoptosis in human neutrophils.
Iwase M; Takaoka S; Uchida M; Kondo G; Watanabe H; Ohashi M; Nagumo M
Int Immunopharmacol; 2006 Mar; 6(3):334-41. PubMed ID: 16428068
[TBL] [Abstract][Full Text] [Related]
24. Relationship between cyclooxygenase 1 and 2 selective inhibitors and fetal development when administered to rats and rabbits during the sensitive periods for heart development and midline closure.
Cappon GD; Cook JC; Hurtt ME
Birth Defects Res B Dev Reprod Toxicol; 2003 Feb; 68(1):47-56. PubMed ID: 12852483
[TBL] [Abstract][Full Text] [Related]
25. LPS-dependent cyclooxygenase-2 induction in human monocytes is down-regulated by IL-13, but not by IFN-gamma.
Endo T; Ogushi F; Sone S
J Immunol; 1996 Mar; 156(6):2240-6. PubMed ID: 8690914
[TBL] [Abstract][Full Text] [Related]
26. Cyclooxygenase-2-selective nonsteroidal anti-inflammatory drugs inhibit hepatocyte growth factor/scatter factor-induced angiogenesis.
Sengupta S; Sellers LA; Cindrova T; Skepper J; Gherardi E; Sasisekharan R; Fan TP
Cancer Res; 2003 Dec; 63(23):8351-9. PubMed ID: 14678996
[TBL] [Abstract][Full Text] [Related]
27. Selective inhibition of cyclooxygenase (COX)-2 reverses inflammation and expression of COX-2 and interleukin 6 in rat adjuvant arthritis.
Anderson GD; Hauser SD; McGarity KL; Bremer ME; Isakson PC; Gregory SA
J Clin Invest; 1996 Jun; 97(11):2672-9. PubMed ID: 8647962
[TBL] [Abstract][Full Text] [Related]
28. Role of cyclooxygenase (COX)-1 and COX-2 inhibition in nonsteroidal anti-inflammatory drug-induced intestinal damage in rats: relation to various pathogenic events.
Tanaka A; Hase S; Miyazawa T; Ohno R; Takeuchi K
J Pharmacol Exp Ther; 2002 Dec; 303(3):1248-54. PubMed ID: 12438549
[TBL] [Abstract][Full Text] [Related]
29. Effect of COX inhibitors on VEGF-induced retinal vascular leakage and experimental corneal and choroidal neovascularization.
Castro MR; Lutz D; Edelman JL
Exp Eye Res; 2004 Aug; 79(2):275-85. PubMed ID: 15325574
[TBL] [Abstract][Full Text] [Related]
30. Role of direct cytotoxic effects of NSAIDs in the induction of gastric lesions.
Tomisato W; Tsutsumi S; Hoshino T; Hwang HJ; Mio M; Tsuchiya T; Mizushima T
Biochem Pharmacol; 2004 Feb; 67(3):575-85. PubMed ID: 15037209
[TBL] [Abstract][Full Text] [Related]
31. Differential inhibition of murine prostaglandin synthase-1 and -2 by nonsteroidal anti-inflammatory drugs using exogenous and endogenous sources of arachidonic acid.
Chulada PC; Langenbach R
J Pharmacol Exp Ther; 1997 Feb; 280(2):606-13. PubMed ID: 9023270
[TBL] [Abstract][Full Text] [Related]
32. Inhibition of cyclooxygenase-2 expression by 4-trifluoromethyl derivatives of salicylate, triflusal, and its deacetylated metabolite, 2-hydroxy-4-trifluoromethylbenzoic acid.
Fernández de Arriba A; Cavalcanti F; Miralles A; Bayón Y; Alonso A; Merlos M; García-Rafanell J; Forn J
Mol Pharmacol; 1999 Apr; 55(4):753-60. PubMed ID: 10101034
[TBL] [Abstract][Full Text] [Related]
33. An introduction to aspirin, NSAIDs, and COX-2 inhibitors for the primary prevention of cardiovascular events and cancer and their potential preventive role in bladder carcinogenesis: part I.
Moyad MA
Semin Urol Oncol; 2001 Nov; 19(4):294-305. PubMed ID: 11769881
[TBL] [Abstract][Full Text] [Related]
34. Origins of prostaglandin E2: involvements of cyclooxygenase (COX)-1 and COX-2 in human and rat systems.
Giuliano F; Warner TD
J Pharmacol Exp Ther; 2002 Dec; 303(3):1001-6. PubMed ID: 12438520
[TBL] [Abstract][Full Text] [Related]
35. Differential inhibition of fracture healing by non-selective and cyclooxygenase-2 selective non-steroidal anti-inflammatory drugs.
Gerstenfeld LC; Thiede M; Seibert K; Mielke C; Phippard D; Svagr B; Cullinane D; Einhorn TA
J Orthop Res; 2003 Jul; 21(4):670-5. PubMed ID: 12798067
[TBL] [Abstract][Full Text] [Related]
36. The COX-2 inhibitor NS-398 causes T-cell developmental disruptions independent of COX-2 enzyme inhibition.
Xu H; Izon DJ; Loftin C; Spain LM
Cell Immunol; 2001 Dec; 214(2):184-93. PubMed ID: 12088417
[TBL] [Abstract][Full Text] [Related]
37. Ascorbic acid enhances the inhibitory effect of aspirin on neuronal cyclooxygenase-2-mediated prostaglandin E2 production.
Candelario-Jalil E; Akundi RS; Bhatia HS; Lieb K; Appel K; Muñoz E; Hüll M; Fiebich BL
J Neuroimmunol; 2006 May; 174(1-2):39-51. PubMed ID: 16529823
[TBL] [Abstract][Full Text] [Related]
38. Tumor necrosis factor alpha and interleukin-1beta stimulate the expression of cyclooxygenase II but do not alter prostaglandin E2 receptor mRNA levels in cultured dorsal root ganglia cells.
Fehrenbacher JC; Burkey TH; Nicol GD; Vasko MR
Pain; 2005 Jan; 113(1-2):113-22. PubMed ID: 15621371
[TBL] [Abstract][Full Text] [Related]
39. Intracellular measurement of prostaglandin E2: effect of anti-inflammatory drugs on cyclooxygenase activity and prostanoid expression.
Horton JK; Williams AS; Smith-Phillips Z; Martin RC; O'Beirne G
Anal Biochem; 1999 Jun; 271(1):18-28. PubMed ID: 10361000
[TBL] [Abstract][Full Text] [Related]
40. Prostaglandin E2 production dependent upon cyclooxygenase-1 and cyclooxygenase-2 and its contradictory modulation by auranofin in rat peritoneal macrophages.
Yamada M; Niki H; Yamashita M; Mue S; Ohuchi K
J Pharmacol Exp Ther; 1997 May; 281(2):1005-12. PubMed ID: 9152412
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
